MYCOPHENOLATE MOFETIL IN THE TREATMENT OF SCLERODERMA-ASSOCIATED DIFFUSE SKIN DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY

被引：0
|
作者：
Rajadurai, A. [1 ]
Ngian, G. [1 ]
Elford, K. [1 ]
Stevens, W. [2 ]
Proudman, S. [3 ]
Roddy, J. [4 ]
Nikpour, M. [2 ]
Youssef, P. [5 ]
Hill, C. [6 ]
Sahhar, J. [1 ]
机构：
[1] Monash Hlth, Clayton, Vic, Australia
[2] St Vincents Hosp, Fitzroy, Vic, Australia
[3] Royal Adelaide Hosp, Adelaide, SA, Australia
[4] Royal Perth Hosp, Perth, WA, Australia
[5] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
[6] Queen Elizabeth Hosp, Adelaide, SA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2015年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARP94
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] DOUBLE-BLIND COMPARISON OF MYCOPHENOLATE MOFETIL AND ORAL CYCLOPHOSPHAMIDE FOR TREATMENT OF SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE (SCLERODERMA LUNG STUDY [SLS] II): RATIONALE, DESIGN, METHODS, BASELINE CHARACTERISTICS AND PATIENT DISPOSITION
    Khanna, D.
    Roth, M.
    Furst, D.
    Clements, P.
    Goldin, J.
    Arriola, E.
    Kotlerman, J.
    Tseng, C. -H.
    Kim, G.
    Elashoff, R.
    Tashkin, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 507 - 507
  • [42] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
    Gisela E Lindahl
    Carmel JW Stock
    Xu Shi-Wen
    Patricia Leoni
    Piersante Sestini
    Sarah L Howat
    George Bou-Gharios
    Andrew G Nicholson
    Christopher P Denton
    Jan C Grutters
    Toby M Maher
    Athol U Wells
    David J Abraham
    Elisabetta A Renzoni
    Respiratory Research, 14
  • [43] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
    Lindahl, Gisela E.
    Stock, Carmel J. W.
    Xu Shi-Wen
    Leoni, Patricia
    Sestini, Piersante
    Howat, Sarah L.
    Bou-Gharios, George
    Nicholson, Andrew G.
    Denton, Christopher P.
    Grutters, Jan C.
    Maher, Toby M.
    Wells, Athol U.
    Abraham, David J.
    Renzoni, Elisabetta A.
    RESPIRATORY RESEARCH, 2013, 14
  • [44] DOES MYCOPHENOLATE MOFETIL (MMF) HAVE AN EFFECT ON PULMONARY HEMODYNAMICS? OBSERVATIONS FROM THE PULMONARY HYPERTENSION ASSESSMENT AND RECOGNITION OF OUTCOMES IN SCLERODERMA (PHAROS) COHORT
    Saketkoo, L.
    Lammi, M.
    Gordon, J.
    Lauto, P.
    Steen, V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S28 - S28
  • [45] Is There a Difference in the Presentation of Diffuse and Limited Subtype of Juvenile Systemic Sclerosis in Childhood? Results from the Juvenile Scleroderma Inception Cohort Www.Juvenile-Scleroderma.Com
    Foeldvari, Ivan
    Klotsche, Jens
    Stanevicha, Valda
    Katsicas, Maria M.
    Terreri, Maria Teresa
    Sakamoto, Ana Paula
    Cimaz, Rolando
    Kostik, Mikhail
    Avcin, Tadey
    Santos, Maria Jose
    Moll, Monika
    Nemkova, Dana
    Sztajnbok, Flavio
    Battagliotti, Cristina
    Brunner, Juergen
    Eleftheriou, Despina
    Sifuentes Giraldo, Alberto
    Harel, Liora
    Janarthanan, Mahesh
    Kallinich, Tilmann
    Minden, Kirsten
    Nielsen, Susan Mary
    Torok, Kathryn S.
    Uziel, Yosef
    Helmus, Nicola
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] Does Mycophenolate Mofetil (MMF) Have An Effect On Pulmonary Hemodynamics? Observations From The Pulmonary Hypertension Assessment and Recognition Of Outcomes In Scleroderma (PHAROS) Cohort
    Saketkoo, Lesley Ann
    Lammi, Matthew R.
    Gordon, Jessica K.
    Lauto, Paula
    Steen, Virginia D.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1101 - S1101
  • [47] Does Mycophenolate Mofetil (mmf) Have An Effect On Pulmonary Hemodynamics? Observations From The Pulmonary Hypertension Assessment And Recognition Of Outcomes In Scleroderma (pharos) Cohort
    Saketkoo, L.
    Lammi, M. R.
    Gordon, J.
    Lauto, P.
    Steen, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] What is the relationship between disease activity, severity and damage in a large Canadian scleroderma cohort? Results from the Canadian scleroderma research group (CSRG)
    Fan, Xiangning
    Pope, Janet
    Baron, Murray
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1196 - 1196
  • [49] Double-Blind Comparison Of Mycophenolate Mofetil And Oral Cyclophosphamide For Treatment Of Scleroderma-Related Interstitial Lung Disease (scleroderma Lung Study [sls] Ii): Rationale, Design, Methods, Baseline Characteristics/intercorrelations And Patient Disposition
    Tashkin, D. P.
    Roth, M. D.
    Furst, D. E.
    Clements, P.
    Khanna, D.
    Goldin, J. G.
    Arriola, E.
    Kotlerman, J.
    Tseng, C. -H.
    Kim, G.
    Elashoff, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [50] Effect of Warfarin On Survival In Scleroderma-Associated and Idiopathic Pulmonary Arterial Hypertension. A Bayesian Approach to Evaluating Treatment In Uncommon Disease
    Johnson, Sindhu R.
    Granton, John T.
    Tomlinson, George A.
    Grosbein, Haddas
    Le, Thaolan
    Lee, Peter
    Seary, M. Elizabeth
    Hawker, Gillian A.
    Feldman, Brian M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S968 - S968
12345